| pubmed-article:16646070 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16646070 | lifeskim:mentions | umls-concept:C0021344 | lld:lifeskim |
| pubmed-article:16646070 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:16646070 | lifeskim:mentions | umls-concept:C0950124 | lld:lifeskim |
| pubmed-article:16646070 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:16646070 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:16646070 | lifeskim:mentions | umls-concept:C0449297 | lld:lifeskim |
| pubmed-article:16646070 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:16646070 | pubmed:dateCreated | 2006-8-24 | lld:pubmed |
| pubmed-article:16646070 | pubmed:abstractText | Persistent infection with high-risk human papillomavirus (HPV) is central to cervical carcinogenesis. Certain high-risk types, such as HPV16, may be more persistent than other HPV types, and type-specific HPV persistence may differ by HIV serostatus. This study evaluated the association between HPV type and clearance of HPV infections in 522 HIV-seropositive and 279 HIV-seronegative participants in the HIV Epidemiology Research Study (HERS, United States, 1993-2000). Type-specific HPV infections were detected using MY09/MY11/HMB01-based PCR and 26 HPV type-specific probes. The estimated duration of type-specific infections was measured from the first HPV-positive visit to the first of two consecutive negative visits. Hazard ratios (HRs) and 95% confidence intervals (CIs) for HPV clearance were calculated using Cox models adjusted for study site and risk behavior (sexual or injection drugs). A total of 1,800 HPV infections were detected in 801 women with 4.4 years median follow-up. HRs for clearance of HPV16 and related types versus low-risk HPV types were 0.79 (95% CI: 0.64-0.97) in HIV-positive women and 0.86 (95% CI: 0.59-1.27) in HIV-negative women. HRs for HPV18 versus low-risk types were 0.80 (95% CI: 0.56-1.16) and 0.57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus. | lld:pubmed |
| pubmed-article:16646070 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16646070 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16646070 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16646070 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16646070 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16646070 | pubmed:issn | 0020-7136 | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:KleinRobert... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:SchumanPaulaP | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:SchroederJane... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:DuerrAnnA | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:Cu-UvinSusanS | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:SmithJennifer... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:JamiesonDenis... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:MarshallSteph... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:ShahKeerti... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:CelentanoDavi... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:HeiligCharles... | lld:pubmed |
| pubmed-article:16646070 | pubmed:author | pubmed-author:KoshiolJill... | lld:pubmed |
| pubmed-article:16646070 | pubmed:copyrightInfo | Copyright 2006 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:16646070 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16646070 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16646070 | pubmed:volume | 119 | lld:pubmed |
| pubmed-article:16646070 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16646070 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16646070 | pubmed:pagination | 1623-9 | lld:pubmed |
| pubmed-article:16646070 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:meshHeading | pubmed-meshheading:16646070... | lld:pubmed |
| pubmed-article:16646070 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16646070 | pubmed:articleTitle | Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. | lld:pubmed |
| pubmed-article:16646070 | pubmed:affiliation | Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. koshiolj@mail.nih.gov | lld:pubmed |
| pubmed-article:16646070 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16646070 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:16646070 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16646070 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16646070 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16646070 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16646070 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16646070 | lld:pubmed |
